TEM deepens collaborations in oncology and neuroscience using its Lens and Next platforms to accelerate precision medicine.

Study finds sensory cells that detect tissue damage, irritants also rein in harmful immune responses to protect the lungs ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI includes both early-stage ...

Enanta Pharmaceuticals (NASDAQ:ENTA) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE) and some of ...

Hilton, Delta Airlines, American Express, Capital One, Sephora and more companies feature on PEOPLE's annual list of 100 ...

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

AbbVie announced an update on their ongoing clinical study. The pharmaceutical giant is conducting a Phase 1b clinical study ...

DelveInsight's Personal Care Contract Manufacturing Market Insights report provides the current and forecast market analysis, ...